is mounjaro a glp-1 agonist What Makes Different From GLP-1? – Bolt Pharmacy Retatrutide vs Mounjaro: triple agonist

[Article] [PubMed] [PMC]11

Some studies have shown value of initial metformin-DPP-4 inhibitor combination therapy in special populations

Results Evidence suggests that GLP-1RAs mitigate psoriasis severity through systemic effects, including weight loss and improved glycemic control, and local immunomodulation, such as the regulation of invariant natural killer T (iNKT) cells and AMPK activation in psoriatic plaques

GLP-1s, while highly effective, are therefore only one piece of a multidisciplinary health care puzzle

These interventions are relatively new, and trials are ongoing for new indicators of obesity-related diseases

All studies tracked adverse events to some extent summary of effect of GLP-1 RA on the outcomes across the studies are reported in Table 3